Drug information for PRIMAQUINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL EQ 15MG BASE Prescription  (Reference Drug) PRIMAQUINE PHOSPHATE Primaquine SANOFI AVENTIS US 8316
2008-08-13 Label

2008-08-13 Letter

2003-06-22 Letter

2003-06-22 Label

Drug Adverse Effects information for PRIMAQUINE

Role code Indications Reaction # Reports
C BACTERIAL SEPSIS ADVERSE DRUG REACTION 1
C BACTERIAL SEPSIS ALANINE AMINOTRANSFERASE INCREASED 1
C BACTERIAL SEPSIS BLOOD ALKALINE PHOSPHATASE INCREASED 1
C BACTERIAL SEPSIS C-REACTIVE PROTEIN INCREASED 1
C BACTERIAL SEPSIS CONJUNCTIVAL HYPERAEMIA 1
C BACTERIAL SEPSIS CYANOSIS 1
C BACTERIAL SEPSIS HYPOTENSION 1
C BACTERIAL SEPSIS LOSS OF CONSCIOUSNESS 1
C BACTERIAL SEPSIS LUNG INFILTRATION 1
C BACTERIAL SEPSIS NAUSEA 1
C BACTERIAL SEPSIS NEUTROPHIL COUNT INCREASED 1
C BACTERIAL SEPSIS PO2 DECREASED 1
C BACTERIAL SEPSIS PYREXIA 1
C BACTERIAL SEPSIS RALES 1
C BACTERIAL SEPSIS RASH ERYTHEMATOUS 1
C BACTERIAL SEPSIS TACHYCARDIA 1
C BACTERIAL SEPSIS VENOUS PRESSURE JUGULAR DECREASED 1
C BACTERIAL SEPSIS VOMITING 1
C FEELING OF RELAXATION BLOOD SODIUM DECREASED 2
C HYPERTENSION BLOOD SODIUM DECREASED 2
C MALARIA PROPHYLAXIS BLOOD SODIUM DECREASED 1
C MENOPAUSE BLOOD SODIUM DECREASED 1
C MOOD ALTERED BLOOD SODIUM DECREASED 1
C PNEUMOCYSTIS JIROVECI PNEUMONIA ADVERSE DRUG REACTION 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA ALANINE AMINOTRANSFERASE INCREASED 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA BLOOD ALKALINE PHOSPHATASE INCREASED 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA C-REACTIVE PROTEIN INCREASED 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA CONJUNCTIVAL HYPERAEMIA 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA CYANOSIS 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA HYPOTENSION 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA LOSS OF CONSCIOUSNESS 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA LUNG INFILTRATION 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA NAUSEA 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA NEUTROPHIL COUNT INCREASED 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA PO2 DECREASED 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA PYREXIA 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA RALES 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA RASH ERYTHEMATOUS 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA TACHYCARDIA 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA VENOUS PRESSURE JUGULAR DECREASED 3
C PNEUMOCYSTIS JIROVECI PNEUMONIA VOMITING 3
C PROPHYLAXIS ADVERSE DRUG REACTION 2
C PROPHYLAXIS ALANINE AMINOTRANSFERASE INCREASED 2
C PROPHYLAXIS BLOOD ALKALINE PHOSPHATASE INCREASED 2
C PROPHYLAXIS C-REACTIVE PROTEIN INCREASED 2
C PROPHYLAXIS CONJUNCTIVAL HYPERAEMIA 2
C PROPHYLAXIS CYANOSIS 2
C PROPHYLAXIS HYPOTENSION 2
C PROPHYLAXIS LOSS OF CONSCIOUSNESS 2
C PROPHYLAXIS LUNG INFILTRATION 2
C PROPHYLAXIS NAUSEA 2
C PROPHYLAXIS NEUTROPHIL COUNT INCREASED 2
C PROPHYLAXIS PO2 DECREASED 2
C PROPHYLAXIS PYREXIA 2
C PROPHYLAXIS RALES 2
C PROPHYLAXIS RASH ERYTHEMATOUS 2
C PROPHYLAXIS TACHYCARDIA 2
C PROPHYLAXIS VENOUS PRESSURE JUGULAR DECREASED 2
C PROPHYLAXIS VOMITING 2
Ads by Google